HOME >> BIOLOGY >> NEWS
Springer editor and author Koki Horikoshi to receive 2006 Japan Academy Prize

Koki Horikoshi (73), professor emeritus at the Tokyo Institute of Technology and Director General of Extremobiosphere Research Center JAMSTEC, has been honored with this year's Japan Academy Prize. The award ceremony was held on July 3, 2006, in the presence of Their Majesties the Emperor and Empress of Japan.

Prof. Horikoshi received the award for his studies on the diversity, physiology, and application of alkaliphilic microorganisms. He was the first person in the world to isolate alkaliphiles (alkaline-loving microorganisms) and opened up a new vista of the microbial world. His creative studies have influenced microbiology throughout the world and established the foundations of a new field of biological research into extremophiles, i.e. microorganisms that prefer extreme conditions. He has also conducted extensive screening for the enzymes produced by alkaliphiles, and made a great impact on industrial applications.

Koki Horikoshi was born in Saitama (Japan) in 1932. He obtained a B.A. and a Ph.D. from the University of Tokyo. He is the author of Alkaliphiles: Genetic Properties and Applications of Enzymes (2006), published by Springer. He founded Springer's international journal Extremophiles and has helped develop the journal as Editor-in-Chief since 1997. He also set up the International Society for Extremophiles in 2002 as founding president and is a lifetime honorary president of the society. He has received many awards for his scientific work, including the Purple Medal (1987), the Gold Medal from the UK's International Biotechnology Society (1991) and the Honda Prize (1992).


'"/>

Contact: Joan Robinson
joan.robinson@springer.com
496-221-487-8130
Springer
20-Jul-2006


Page: 1

Related biology news :

1. Springer launches Theoretical Ecology
2. Springer ecology book wins award for excellence
3. Springer author receives prestigious award in Beijing
4. Springer adds Genomic Medicine to biomedical publishing portfolio
5. Springer launches new journal, Cognitive Neurodynamics
6. Springer to publish new journal Systems and Synthetic Biology
7. Springer expands life science program with In Vitro journals
8. Springer author Alan Hastings wins Robert H. MacArthur Award
9. Springer acquires BioTribune Magazine and Biotribune.com
10. Springer joins Katrina relief effort with eBooks donation worth more than $1 million
11. Press Week for science writers, reporters and editors

Post Your Comments:
(Date:10/16/2014)... 2014) – Post-menopausal women experienced improvements in vaginal ... or genital bleeding, after 12 weeks of daily ... soy germ-based nutritional supplement previously shown to help ... peer-reviewed pilot study reported in a poster at ... meeting. , "These data documented improved vaginal ...
(Date:10/15/2014)... the pandemic risk from strains of influenza virus increases ... ourselves to become complacent that the most substantial threats ... , Influenza pandemics arise when a new virus strain ... immunity – spreads in the human population. There have ... the worst of which – the 1918 Spanish Flu ...
(Date:10/15/2014)... spreading rapidly and to an unexpected extent. The outbreak ... and the virus shows a new disease dynamic in ... this reason, the German National Academy of Sciences Leopoldina, ... and the Union of the German Academies of Sciences ... epidemic today. , In the statement the academies call ...
Breaking Biology News(10 mins):S-equol supplements associated with improved measures of reproductive health in postmenopausal women 2Scientists 'must not become complacent' when assessing pandemic threat from flu viruses 2Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5
(Date:10/22/2014)... Hill, SC (PRWEB) October 22, 2014 ... expansion of its cardiovascular pharmacogenetics menu, which enables ... patient outcomes. With PCLS’s evidence-based results, healthcare ... needs and optimize their therapy, while minimizing risks ... In the U.S., according to the FDA [1] ...
(Date:10/22/2014)... , Oct. 22, 2014 /PRNewswire/ - iCo Therapeutics ... today announced next steps for its Oral Amphotericin ... from its in vitro work involving ... iCo now plans to complete pre clinical studies ... initial Phase 1A clinical trial, utilizing approximately $700,000 ...
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
(Date:10/20/2014)... 2014 Convey Computer , the ... from Iowa State University won first place in the ... Convey HC-2ex, the team’s solution achieved the highest overall ... the second place finisher. , Experts from all segments ... month long challenge, using a variety of design tools, ...
Breaking Biology Technology:PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 2PCLS Announces Expansion of Cardiovascular Pharmacogenetic Testing Menu 3iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
Cached News: